Brief: Poxel FY Revenue Rises To EUR 13.4 Million

Poxel SA

16/02/2022 17:54

Feb 16 (Reuters) - Poxel SA  POXEL.PA :
    * FY REVENUE 13.4 MILLION EUR
    * AS OF DECEMBER 31, 2021, CASH AND CASH EQUIVALENTS WERE
EUR 32.3
MILLION (USD 36.6 MILLION)
    * RESULTS OF PXL065 PHASE 2 (DESTINY-1) TRIAL IN NASH
EXPECTED IN
Q3 2022
    * FAST TRACK DESIGNATION (FTD) GRANTED TO PXL065 FOR
ADRENOLEUKODYSTROPHY (ALD); PHASE 2A CLINICAL PROOF-OF-CONCEPT
(POC) BIOMARKER PROGRAM NOW ANTICIPATED TO START MIDYEAR, WITH
RESULTS TO FOLLOW IN EARLY 2023

Source text for Eikon:  ID:nBw2d2S7za 
Further company coverage:  POXEL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))